Type 2 diabetes and cardiovascular disease are directly linked — but not because of blood sugar. Metabolic disorders play the major role in increasing heart disease risk in diabetic patients.
Miami Cardiac & Vascular Institute’s cardiometabolic and prevention center is taking a comprehensive approach to these patients, aimed at controlling blood pressure, cholesterol, triglycerides, obesity and other factors. Medications can play a role that goes beyond treating symptoms to actually helping prevent negative cardiac events.
Host, Jonathan Fialkow, M.D., a preventative cardiologist at Miami Cardiac & Vascular Institute, welcomes guests Lisa Davis, PA, a clinical lipid specialist, and clinical pharmacist Jennifer Miles, Pharm.D., for a discussion about using medications to reduce diabetic cardiac risk.